Use Probiotec Limited (#AU000000PBP7AU) historical price analysis together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.
The price series of Probiotec for the period between Tue, Nov 12, 2013 and Thu, Dec 12, 2013 has a statistical range of 0.07 with a coefficient of variation of 6.05. The price distribution for the period has arithmetic mean of 0.4. The median price for the last 30 days is 0.4
Probiotec Limited is rated below average in market capitalization category among related companies. Market capitalization of Drugs - Generic industry is at this time estimated at about 2.75 Billion. Probiotec maintains roughly 22.23 Million in market capitalization contributing less than 1% to equities under Drugs - Generic industry.
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory